Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
Joseph Baron is a partner at Extera Partners, which provides innovative life science companies with interim senior management, business strategy consulting, and hands-on implementation of growth strategies in the U.S. and Europe.
More GEN Content From This Contributor:
- GEN Exclusives: How Biotech Unions Could Save Companies and Revitalize Pipelines